In the first human test, an enzyme-converted kidney was transplanted into a brain-dead recipient with family consent, ...

Cedars-Sinai researchers created “young” immune cells from human stem cells that reversed cognitive decline and Alzheimer’s ...

Murray’s claim that terminal lucidity refutes materialism rests on a questionable presupposition. It assumes that, on a ...

Following his mysterious death, a spiritual blogger claims to have received a message from Yu Menglong: 'I am willing to shed ...

Experts blame misinformation and “vaccine fatigue” for declining demand for flu shots. Here's what you should know about flu ...

From alien-like carcasses to severed feet, and more, here are the weirdest and grossest things ever found on a beach, and the ...

It’s still early days. Nobody’s suggesting we’ll all start “breathing through our butts.” But medical innovation has a habit ...

People who appear fit but carry dangerous fat around their internal organs face the same artery damage as visibly overweight ...

Welcome to the sixth installment of “Dissertation Diaries.” We will be highlighting Machlan Sawden, a fifth-year Ph.D. student in the Shruti Sharma Lab at the Tufts Graduate School of Biomedical ...

Drug trafficking, beyond being a crime, is a multibillion-dollar transnational enterprise that buys countries, corrupts their ...

A new DNA-based therapy could cut cholesterol nearly in half—without relying on statins or causing side effects.

Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, has opened a unique perfusion 'Liver ICU' lab in the Alexandria Centre for Life Sciences.